Patent №
US 11,670,409
Granted
2023-06-06
Filed 2018
Owner
BAXALTA INCORPORATED
Lab
—
AI components
3
kr · planning · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
16092396
Systems and methods for providing a clotting factor VIII (CFVIII) dosing regimen include collecting two blood samples from a patient after an infusion of CFVIII and determining a CFVIII clearance based on the two blood samples, and determining if a patient has a half-life greater than a predetermined threshold. A pharmacokinetic (PK) profile of the patient is determined using a Bayesian model of pharmacokinetic profiles of sampled patients having similar body weight or age of the patient. A first weight is applied to the Bayesian model of pharmacokinetic profiles of sampled patients if the half-life of the patient is greater than the predetermined threshold, and a second weight, less than the first weight, is applied to the Bayesian model of pharmacokinetic profiles of sampled patients if the half-life of the patient is less than the predetermined threshold. A dosing regimen is determined for the patient based on the PK profile.
AI classification
Ownership
BAXALTA INCORPORATED
assignment · 478930156
Assignors
KUCHIMANCHI, KAMESWARA RAO, LOEW-BASELLI, ALEXANDRA, SPOTTS, GERALD, OH, MYUNGSHIN, HALE, MICHAEL DON, WOLFSEGGER, MARTIN
On an employer assignment, the assignors are typically the inventors.